Viewing Study NCT00970502

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2026-02-07 @ 5:17 PM
Study NCT ID: NCT00970502
Status: COMPLETED
Last Update Posted: 2017-04-10
First Post: 2009-09-01
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
Sponsor: Johnny Kao
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer of the Pharynx View
None Cancer of the Larynx View
None Cancer of the Neck View
None Paranasal Sinus Neoplasms View
None Cancer of the Head View
Keywords:

Keywords

Keyword Brief Keyword Text View
None celecoxib View
None erlotinib View
None epidermal growth factor receptor View
None intensity-modulated radiotherapy View
None cyclooxygenase-2 View
None reirradiation View